SNTI | tickerfilter.com

Fundamental analysis

15%

Profitability 0%

Dept financing 12%

Liquidity 75%

Performance 16%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-7.49%

1 Month

-26.38%

3 Months

-37.18%

6 Months

9.93%

1 Year

781.14%

2 Year

130.94%

Key data

Stock price

$3.21

P/E Ratio

0.00

DAY RANGE

$3.15 - $3.40

EPS

-$2.45

52 WEEK RANGE

$0.21 - $16.94

52 WEEK CHANGE

$760.59

MARKET CAP

10.348 M

YIELD

N/A

SHARES OUTSTANDING

4.579 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

3.66

PUBLIC FLOAT

AVERAGE 10 VOLUME

$36,752

AVERAGE 30 VOLUME

$42,402

Company detail

CEO: Timothy K. Lu
Region: US
Website: sentibio.com
Employees: 4
IPO year: 2022

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Dynamics Special Purpose Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination. The company was incorporated in 2021 and is based in Redwood City, California.

SNTI - Senti Biosciences Inc.